{
    "code": "01016209",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01016209",
    "time": "2017-07-21 14:37:51",
    "許可證字號": "衛署藥製字第016209號",
    "註銷狀態": "已註銷",
    "註銷日期": "99\/02\/08",
    "註銷理由": "屆期未申請展延",
    "有效日期": "93\/12\/20",
    "發證日期": "67\/12\/20",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00101620902",
    "中文品名": "樂賜平口服懸浮液２５公絲\/５公撮",
    "英文品名": "LOXAPAC LOXAPINE ORAL SUSPENSION 25MG\/5ML",
    "適應症": "急、慢性精神分裂症之治療以及腦器質症候群或精神遲鈍所引起之精神異狀。",
    "劑型": "183懸液劑",
    "包裝": "瓶裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": [
        "LOXAPINE"
    ],
    "限制項目": "01國　產",
    "申請商名稱": "1409901200  臺灣惠氏股份有限公司新竹廠",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "1409906300  臺灣惠氏股份有限公司新竹廠",
        "製造廠廠址": "新竹縣新豐鄉中崙村中崙二九０之一號",
        "製造廠公司地址": "",
        "": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses,put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2816800800",
            "成分名稱": "LOXAPINE",
            "含量描述": "25",
            "含量": "25.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "010162090001.doc",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01016209&Seq=001&Type=9"
        }
    ]
}